In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline’s Arexvy vaccine to include adults aged 50 to 59 who face a heightened risk from respiratory syncytial virus (RSV) due to underlying health conditions. This expanded approval marks a significant move in Canada’s battle against RSV, a respiratory virus that, […]
In a blockbuster move set to shake up the market, Pfizer has announced its plan to sell approximately 540 million ordinary shares in Haleon, one of the largest consumer healthcare companies in the world. This sale represents about 5.9% of Haleon’s total share capital and reflects Pfizer’s ongoing strategy to reduce its non-core assets. Pfizer, […]
Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the US Food & Drug Administration (FDA). The approved product is the generic version of GlaxoSmithKline’s Compazine Tablets, 5 mg and 10 mg. Compazine is indicated for the treatment of nausea, schizophrenia, migraines, anxiety, and psychosis. Glenmark Pharmaceuticals […]
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (FDA) for Ibuprofen Oral Suspension USP, 50 mg/1.25 mL (40 mg/mL) (OTC). The pain drug product from Strides Pharma is the generic of GlaxoSmithKline Consumer Healthcare Holdings (US)’s […]
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to $3.3 billion. The consideration includes an upfront payment of $2.1 billion and payments of up to $1.2 billion based on potential development milestones. Affinivax is engaged in developing vaccines by using its Multiple Antigen Presenting System (MAPS) […]
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9 billion (£1.5 billion). As per the terms of the deal, shareholders of the publicly-listed Sierra Oncology will be paid $55 per share in cash. Sierra Oncology is engaged in developing targeted therapies for the treatment of rare […]
GlaxoSmithKline Pharmaceuticals Limited said that it will transfer its rights pertaining to the Iodex pain relief and Ostocalcium brands to GlaxoSmithKline Asia Private Limited for INR 1,649 crores. The deal, which will be subject to approval from shareholders, regulatory approvals, and customary closing conditions, is expected to be closed by the end of the year. […]
Dr. Reddy’s Laboratories has launched Albendazole Tablets, USP, a generic version of GlaxoSmithKline’s Albenza Tablets, 200 mg, which are used for the treatment of a range of parasitic worm infestations. Approved by the US Food and Drug Administration (FDA), Albenza brand and generic had sales of around $27 million MAT for the most recent twelve […]
Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment of HIV-1 infection in adult patients. According to ViiV Healthcare, Cabenuva is being given as a co-pack with a couple of injectable medicines that include the company’s integrase strand transfer […]
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]